12 September 2012, New Delhi. Continuing arguments on behalf of Novartis, Mr Gopal Subramaniam, senior counsel, took the Bench through the Complete Specification of Novartis’ patent application for the beta-crystalline form of imatinib mesylate that was filed before the Patent Controller in India. He said that it has to be ascertained whether the application has…

2014 © Copyright - Lawyers Collective Designed by CGD

Current News